Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Cash from Financing Activities (2016 - 2026)

Bruker filings provide 16 years of Cash from Financing Activities readings, the most recent being -$167.6 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 123.47% to -$167.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $135.1 million, a 89.01% decrease, with the full-year FY2025 number at $135.1 million, down 89.01% from a year prior.
  • Cash from Financing Activities hit -$167.6 million in Q4 2025 for Bruker, down from $258.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $1.2 billion in Q2 2024 to a low of -$217.4 million in Q1 2022.
  • Median Cash from Financing Activities over the past 5 years was -$37.1 million (2021), compared with a mean of $53.7 million.
  • Biggest five-year swings in Cash from Financing Activities: tumbled 3053.85% in 2022 and later soared 11321.36% in 2024.
  • Bruker's Cash from Financing Activities stood at $404.3 million in 2021, then tumbled by 108.93% to -$36.1 million in 2022, then plummeted by 65.93% to -$59.9 million in 2023, then dropped by 25.21% to -$75.0 million in 2024, then plummeted by 123.47% to -$167.6 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$167.6 million (Q4 2025), $258.4 million (Q3 2025), and $95.5 million (Q2 2025) per Business Quant data.